Brought to you by 
Cytokinetics raises $20mm in Series B preferred offering
12 Oct 1999
Executive Summary
Cellular bioinformatics start-up Cytokinetics raised $20mm in a Series B preferred stock private placement.through new investors International Biomedicine Holdings, Vulcan Ventures (both of which led the round), Duke University, and New Medical Technologies, joined by returning participants Mayfield Fund and Sevin Rosen Funds.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cytokinetics raises $20mm in Series B preferred offering
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice